Your browser is no longer supported. Please, upgrade your browser.
ABBV AbbVie Inc. daily Stock Chart
ABBV [NYSE]
AbbVie Inc.
IndexS&P 500 P/E42.20 EPS (ttm)2.23 Insider Own0.09% Shs Outstand1.50B Perf Week-3.64%
Market Cap141.28B Forward P/E8.96 EPS next Y10.52 Insider Trans1.23% Shs Float1.48B Perf Month7.09%
Income3.32B PEG11.51 EPS next Q2.24 Inst Own76.50% Short Float5.06% Perf Quarter6.20%
Sales32.87B P/S4.30 EPS this Y4.80% Inst Trans1.87% Short Ratio8.98 Perf Half Y41.89%
Book/sh-5.55 P/B- EPS next Y8.79% ROA7.00% Target Price100.42 Perf Year17.80%
Cash/sh7.10 P/C13.27 EPS next 5Y3.67% ROE-49.50% 52W Range62.66 - 97.86 Perf YTD6.43%
Dividend4.72 P/FCF21.16 EPS past 5Y7.60% ROI21.80% 52W High-2.52% Beta1.04
Dividend %5.01% Quick Ratio1.00 Sales past 5Y11.80% Gross Margin77.00% 52W Low52.25% ATR2.02
Employees30000 Current Ratio1.20 Sales Q/Q3.00% Oper. Margin21.70% RSI (14)64.98 Volatility1.81% 2.16%
OptionableYes Debt/Eq- EPS Q/Q-30.00% Profit Margin12.40% Rel Volume0.60 Prev Close94.23
ShortableYes LT Debt/Eq- EarningsFeb 07 BMO Payout148.90% Avg Volume8.33M Price95.40
Recom2.20 SMA207.47% SMA507.47% SMA20021.83% Volume3,617,461 Change1.24%
Feb-06-20Initiated Mizuho Buy
Jan-07-20Initiated RBC Capital Mkts Sector Perform $86
Dec-26-19Reiterated Cowen Outperform $90 → $98
Sep-26-19Upgrade Citigroup Neutral → Buy $87 → $90
Aug-20-19Upgrade Piper Jaffray Neutral → Overweight $80
Jun-27-19Upgrade Wolfe Research Underperform → Peer Perform
Jun-26-19Upgrade SVB Leerink Mkt Perform → Outperform $88
May-28-19Initiated Goldman Neutral
Apr-29-19Upgrade BMO Capital Markets Underperform → Market Perform
Mar-25-19Downgrade Argus Buy → Hold
Jan-23-19Initiated UBS Neutral $91
Jan-03-19Downgrade BofA/Merrill Buy → Neutral
Dec-26-18Initiated Standpoint Research Buy
Oct-22-18Reiterated SunTrust Buy $157 → $135
Oct-04-18Reiterated BofA/Merrill Buy $107 → $106
Jun-01-18Downgrade Piper Jaffray Overweight → Neutral
May-30-18Downgrade Credit Suisse Neutral → Underperform
Jan-30-18Reiterated Morgan Stanley Equal-Weight $99 → $131
Jan-29-18Downgrade Leerink Partners Outperform → Mkt Perform
Oct-30-17Reiterated Leerink Partners Outperform $108 → $107
Feb-21-20 09:58AM  Zacks Value Trader Highlights: AbbVie, Allergan, Occidental, Chevron and CVS Zacks
05:35AM  Form 8.3 - Abbvie Plc Business Wire
Feb-20-20 04:46PM  Disagreement on Japan Evacuees; Cops Quarantined: Virus Update Bloomberg
01:14PM  AbbVie Declares Quarterly Dividend PR Newswire
12:37PM  David Abrams Buys 2 Stocks in 4th Quarter GuruFocus.com
11:42AM  Nations largest insurer invests in Waltham healthcare AI startup American City Business Journals
09:53AM  FORM 8.3 - ABBVIE INC - Amendment Business Wire
06:06AM  Form 8.3 - Abbvie Plc Business Wire
Feb-19-20 02:02PM  Abbott Laboratories: Why Adding More of This Health Care Giant Makes Sense GuruFocus.com
09:51AM  Jim Simons: The Investing Guru Bets on These 3 Healthcare Stocks TipRanks
09:18AM  Form 8.3 - ABBVIE INC - AMENDMENT Business Wire
08:00AM  AbbVie to Present at the Cowen 40th Annual Health Care Conference PR Newswire
07:11AM  FORM 8.3 - ABBVIE INC Business Wire
Feb-18-20 02:56PM  Consumer groups, unions oppose fix for planned merger of AbbVie and Allergan Reuters
10:00AM  AbbVie's $63 Billion Allergan Takeover Is Looming Is It Time To Add Shares? Investor's Business Daily
Feb-17-20 08:36AM  FORM 8.3 - ABBVIE INC - Amendment Business Wire
07:00AM  FORM 8.3 - ABBVIE INC Business Wire
05:04AM  Form 8.3 - ABBVIE INC - AMENDMENT Business Wire
Feb-15-20 01:17PM  Veteran strategist eyes health care and financials in anticipation of choppy and frustrating markets MarketWatch
Feb-14-20 09:52AM  Pharma Stock Roundup: ABBV, AGN Post Q4 Results, Another Alzheimer's Study Fails Zacks
09:22AM  The Keys to Successfully Timing the Markets - February 14, 2020 Zacks
06:18AM  FORM 8.3 - ABBVIE INC Business Wire
Feb-13-20 07:10AM  FORM 8.3 - ABBVIE INC Business Wire
06:00AM  AbbVie's SKYRIZI Now Listed on the Nova Scotia Formulary for the Treatment of Moderate to Severe Plaque Psoriasis CNW Group
Feb-12-20 04:27PM  Edited Transcript of ABBV earnings conference call or presentation 7-Feb-20 2:00pm GMT Thomson Reuters StreetEvents
10:30AM  Buy AbbVie for its Growth Prospects, Yield and Low Valuation GuruFocus.com
09:59AM  Form 8.3 - Abbvie Plc - Amendment Business Wire
09:43AM  The Zacks Analyst Blog Highlights: AbbVie, Accenture, TOTAL, Amazon.com and Intuit Zacks
07:23AM  FORM 8.3 - ABBVIE PLC Business Wire
05:16AM  Form 8.3 - ABBVIE INC - Amendment Business Wire
Feb-11-20 02:18PM  Coronavirus update: 1,018 deaths, a new case in San Diego, 195 evacuees expected to leave quarantine MarketWatch
01:09PM  Top Stock Research Reports for AbbVie, Accenture, TOTAL & Others Zacks
08:00AM  AbbVie to Present at the SVB Leerink 9th Annual Global Healthcare Conference PR Newswire
07:33AM  Form 8.3 - ABBVIE INC Business Wire
04:51AM  Form 8.3 - Abbvie Plc - Amendment Business Wire
Feb-10-20 04:18PM  Allergan Rides Botox Sales To Top Forecasts As AbbVie Merger Looms Investor's Business Daily
03:11PM  Allergan (AGN) Surpasses Q4 Earnings and Sales Estimates Zacks
11:47AM  Wall Street Opens Higher Monday GuruFocus.com
09:31AM  Allergan Tops Q4 Earnings Forecast, Sees $63 Billion AbbVie Deal Closing in Q1 TheStreet.com
09:03AM  Easy Investing Secrets to an Early Retirement - February 10, 2020 Zacks
07:14AM  Allergan's stock rises as adjusted profit, revenue beat expectations MarketWatch
06:53AM  Form 8.3 - ABBVIE INC Business Wire
04:48AM  AbbVie Stock Rises 3% Investing.com
Feb-07-20 04:22PM  Stocks end lower as market retreats from records MarketWatch +5.86%
04:08PM  AbbVie Stock Breaks Out As Humira Sales Top Bearish Expectations Investor's Business Daily
04:01PM  US Stock Market Red on Friday GuruFocus.com
02:07PM  AbbVie's (ABBV) Q4 Earnings Beat, 2020 View Solid, Stock Up Zacks
10:34AM  FORM 8.3 - ABBVIE PLC - AMENDMENT Business Wire
10:24AM  Pharma Stock Roundup: BMY, GSK, SNY Q4 Results, MRK Earnings & Split Zacks
10:20AM  AbbVie Tops Q4 Profit Forecast, Sees Solid 2020 as New Drugs Boost Sales TheStreet.com
09:33AM  AbbVie Jumps on Strong Earnings. Thats Not the Only Reason. Barrons.com
09:05AM  AbbVie (ABBV) Q4 Earnings and Revenues Beat Estimates Zacks
08:11AM  AbbVie Reports Q4 Earnings Beat Benzinga
08:10AM  AbbVie's stock rises on strong earnings MarketWatch
07:46AM  New drugs contribute to AbbVie's upbeat 2020 view; shares hit year-high Reuters
07:43AM  AbbVie Reports Full-Year and Fourth-Quarter 2019 Financial Results PR Newswire
05:45AM  Form 8.3 - ABBVIE INC Business Wire
04:33AM  AbbVie Stock Rises 3% Investing.com
02:45AM  AbbVie Earnings Beat, Revenue Inline In Q4 Investing.com
Feb-06-20 08:39PM  AbbVie boosts 2020 outlook despite competition from generic drugs Financial Times
01:21PM  Q4 Earnings Outlook For AbbVie Benzinga
11:38AM  Form 8.3 - ABBVIE INC - Amendment Business Wire
10:54AM  AbbVie Climbs Pre-Earnings on Analyst Nod, Coronavirus Drug Demand TheStreet.com
10:51AM  Allergan (AGN) to Report Q4 Earnings: What's in the Cards? Zacks
03:43AM  Form 8.3 - ABBVIE INC - AMENDMENT Business Wire
Feb-05-20 11:17AM  Regeneron Expands Agreement to Develop Coronavirus Therapy Zacks
10:37AM  Can Humira/Cancer Drugs Help AbbVie (ABBV) Beat Q4 Earnings? Zacks
09:28AM  FORM 8.3 - ABBVIE INC - Amendment Business Wire
08:45AM  RINVOQ (upadacitinib) Meets Primary and Key Secondary Endpoints in Phase 3 Study in Psoriatic Arthritis PR Newswire
08:43AM  AbbVie Stock Rises 3% Investing.com
06:55AM  Form 8.3 - ABBVIE INC Business Wire
04:48AM  FORM 8.3 - ABBVIE INC AMENDMENT Business Wire
Feb-04-20 04:15PM  Merck's Keytruda: How Long Can It Fend Off Cancer-Treatment Rivals? Investor's Business Daily
12:08PM  Merck's Keytruda: How Long Can It Fend Off Cancer-Treatment Rivals? Investor's Business Daily
09:44AM  FORM 8.3 - ABBVIE PLC - AMENDMENT Business Wire
08:03AM  AbbVie (ABBV) to Report Q4 Earnings: What's in the Cards? Zacks
07:17AM  FORM 8.3 - ABBVIE INC Business Wire
Feb-03-20 05:45PM  AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know Zacks
04:26PM  CDC Readies for Pandemic; Long Vaccine Timeline: Virus Update Bloomberg
11:16AM  Vaxart (VXRT) to Make Vaccines to Check Coronavirus, Stock Up Zacks
10:10AM  VVUS: ZenPep Deal Demonstrates PERT Interest Zacks Small Cap Research
10:10AM  AZRX: EPI Treatment in the News Zacks Small Cap Research
06:20AM  AZRX: EPI Treatment in the News Zacks Small Cap Research
03:25AM  Stocks - Apple Falls in Premarket; Drug Reports Lift Gilead, AbbVie Investing.com
Jan-31-20 10:16PM  Top Marijuana Stocks That Pay Dividends Investopedia
04:53PM  Lilly's Olumiant Succeeds in Another Late-Stage Eczema Study Zacks
09:54AM  Form 8.3 - Abbvie Plc Business Wire
08:54AM  Amgen (AMGN) Stock Down Despite Q4 Earnings & Revenue Beat Zacks
08:25AM  Decisions, Decisions: AbbVie or Bristol-Myers Squibb? TheStreet.com
07:15AM  AbbVie Receives Positive CHMP Opinion for MAVIRET® (glecaprevir/pibrentasvir) to Shorten Treatment Duration to Eight Weeks in Genotype 3, Treatment-Naïve Patients with Chronic Hepatitis C and Compensated Cirrhosis PR Newswire
06:55AM  AbbVie Receives Positive CHMP Opinion for VENCLYXTO® as a Chemotherapy-Free Combination Regimen for Patients with Previously Untreated Chronic Lymphocytic Leukemia PR Newswire
Jan-30-20 06:21PM  J&J (JNJ) Plans to Develop Vaccine for New Coronavirus Zacks
03:40PM  Coronavirus update: US records first human-to-human transmission as WHO declares global emergency Yahoo Finance
10:51AM  Biogen (BIIB) Surpasses Q4 Earnings and Sales Estimates Zacks
10:05AM  Form 8.3 - Abbvie Plc - Amendment Business Wire
10:02AM  Form 8.3 - ABBVIE INC - Amendment Business Wire
09:42AM  FORM 8.3 - ABBVIE PLC Business Wire
08:00AM  Slapping Around Martin Shkreli Wont Cut Drug Prices Bloomberg
Jan-29-20 06:16PM  Best Dividend Stocks for February 2020 Investopedia
05:57PM  Joel Greenblatt: Is There Still an Edge to Be Found in the Market? GuruFocus.com
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products in the United States, Japan, Germany, Canada, Italy, Spain, the Netherlands, the United Kingdom, Brazil, and internationally. It offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behcet's diseases; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenstrom's macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus (HCV); TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides KALETRA, an anti-human immunodeficiency virus (HIV)-1 medicine used with other anti-HIV-1 medications to maintain viral suppression in HIV-1 patients; NORVIR, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1; and SYNAGIS to prevent respiratory syncytial virus infection at-risk infants. In addition, it offers AndroGel, a testosterone replacement therapy; CREON, a pancreatic enzyme therapy; Synthroid to treat hypothyroidism; and Lupron to treat prostate cancer, endometriosis, and central precocious puberty, as well as anemia. Further, it provides Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Sevoflurane, an anesthesia product; and ORILISSA, a non-peptide molecule gonadotropin-releasing hormone antagonist. It has collaborations with Alector, Inc.; Janssen Biotech, Inc.; Galapagos; Bristol-Myers Squibb Company; Calico Life Sciences LLC; Cystic Fibrosis Foundation; Dragonfly Therapeutics, Inc.; and Pan-Canadian Pharmaceutical Alliance. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RICHMOND TIMOTHY J.EVP, Chief HR OfficerSep 27Sale75.0215,5151,163,8730Oct 01 05:52 PM
Schumacher Laura JVice ChairmanSep 16Buy70.4225,0001,760,523164,838Sep 18 04:25 PM
Donoghoe NicholasSVP, Enterprise InnovationAug 29Buy66.197,525498,05713,090Aug 30 04:08 PM
Stewart Jeffrey RyanSVP, US Commercial OperationsAug 16Buy64.4415,5521,002,16965,304Aug 20 04:16 PM
AUSTIN ROXANNE SDirectorAug 01Buy65.6625,0001,641,400117,114Aug 02 05:02 PM
AUSTIN ROXANNE SDirectorJul 31Buy66.0230,0001,980,69092,114Aug 02 05:02 PM
AUSTIN ROXANNE SDirectorJul 30Buy66.3510,000663,50062,114Jul 31 04:46 PM
Gosebruch Henry OEVP, Chief Strategy OfficerJul 29Buy67.2830,0002,018,38575,763Jul 31 04:46 PM
AUSTIN ROXANNE SDirectorJun 26Buy67.5011,500776,25052,114Jun 28 04:47 PM
CHASE WILLIAM JEVP, Finance & AdministrationJun 26Buy67.3030,4002,045,920169,552Jun 28 04:47 PM
RAPP EDWARD JDirectorJun 26Buy67.307,500504,75030,662Jun 28 04:48 PM
Durkin Brian LVP, ControllerMar 25Sale79.6947537,8539,121Mar 25 04:34 PM
Schumacher Laura JVice ChairmanMar 14Sale80.0025,0002,000,000139,838Mar 15 05:53 PM
SALEKI-GERHARDT AZITAEVP, OperationsMar 05Sale79.0315,7971,248,48093,312Mar 06 05:03 PM